All In Biotech

Drug Trial Radar · NCT06272487

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Adult Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications

Last checked: Nov 20, 2026Latest source record: Mar 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 375 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

375

Actual

Start

Feb 29, 2024

Primary completion

Jun 19, 2025

Study completion Dec 1, 2025

Sponsor

Lead sponsor
Alnylam PharmaceuticalsAlnylam Pharmaceuticals (ALNY)
Sponsor type
Industry
First posted
Feb 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effect of zilebesiran as add-on therapy in patients with high cardiovascular risk and hypertension not adequately controlled by standard of care antihypertensive medications.

Conditions

  • High Cardiovascular Risk
  • Hypertension

Interventions

  • ZilebesiranDrug

    Zilebesiran administered by subcutaneous (SC) injection

  • PlaceboDrug

    Placebo administered by SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline at Month 3 in Mean Seated Office Systolic Blood Pressure (SBP)Time frame: Baseline and Month 3

Locations

195 sites in 6 countries. Site status is shown where the registry gives one.

  • Clinical Trial Site

    Alexander City, Alabama

  • Clinical Trial Site

    Daphne, Alabama

  • Clinical Trial Site

    Foley, Alabama

  • Clinical Trial Site

    Huntsville, Alabama

  • Clinical Trial Site

    Huntsville, Alabama

  • Clinical Trial Site

    Montgomery, Alabama

  • Clinical Trial Site

    Gilbert, Arizona

  • Clinical Trial Site

    Phoenix, Arizona

  • Clinical Trial Site

    Sun City, Arizona

  • Clinical Trial Site

    Tempe, Arizona

  • Clinical Trial Site

    Tucson, Arizona

  • Clinical Trial Site

    Beverly Hills, California

  • Clinical Trial Site

    Covina, California

  • Clinical Trial Site

    Encinitas, California

  • Clinical Trial Site

    Garden Grove, California

  • Clinical Trial Site

    Huntington Beach, California

  • Clinical Trial Site

    Los Angeles, California

  • Clinical Trial Site

    Los Angeles, California

  • Clinical Trial Site

    Northridge, California

  • Clinical Trial Site

    Northridge, California

  • Clinical Trial Site

    Pasadena, California

  • Clinical Trial Site

    San Diego, California

  • Clinical Trial Site

    San Diego, California

  • Clinical Trial Site

    San Dimas, California

  • Clinical Trial Site

    Simi Valley, California

  • Clinical Trial Site

    Vacaville, California

  • Clinical Trial Site

    Van Nuys, California

  • Clinical Trial Site

    West Hills, California

  • Clinical Trial Site

    Colorado Springs, Colorado

  • Clinical Trial Site

    Denver, Colorado

  • Clinical Trial Site

    Denver, Colorado

  • Clinical Trial Site

    Hartford, Connecticut

  • Clinical Trial Site

    Middlebury, Connecticut

  • Clinical Trial Site

    Waterbury, Connecticut

  • Clinical Trial Site

    Washington D.C., District of Columbia

  • Clinical Trial Site

    Clearwater, Florida

  • Clinical Trial Site

    Coral Gables, Florida

  • Clinical Trial Site

    Daytona Beach, Florida

  • Clinical Trial Site

    Fort Myers, Florida

  • Clinical Trial Site

    Hollywood, Florida

Showing 40 of 195 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.